Mr. Chair, I want to thank Ms. Davies for this initiative.This is a big problem; there is no doubt about that. The debts of gratitude created in our health care professionals by pharmaceutical companies giving them everything from pens to coffee cups to free lunches to free trips, just goes on and on. And it's proven by research to influence prescribing practices.
The Canadian Medical Association should do this voluntarily. They haven't, obviously. My concern is that this isn't related to the safety of a therapeutic product directly, and it could possibly be challengeable because it's not fully under federal jurisdiction, although that's not my primary concern. This bill is about the safety of therapeutic products, and as such is outside the scope of the bill. If the member introduced a private member's bill on this, I'd be happy to support it.